Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
The FDA has approved three GLP-1s in particular for both type 2 diabetes treatment and weight loss: Liraglutide (Saxenda, Victoza): While effective, this once-daily injection generally leads to more modest weight loss compared to newer options (its been around since 2014)
A large study that compared tirzepatide to semaglutide showed that in non-diabetic, overweight adults, the risk of gastroparesis was much higher in semaglutide recipients compared to tirzepatide
Test and refine based on sales data and feedback.
At JosephCareRX, we emphasize the importance of GLP-1 because of its significant role in managing blood sugar levels, appetite control, and overall metabolic health
Disclaimer: This information is provided for product guidance and does not replace advice from a physician or pharmacist
